Blueprint Medicines Corp Asset Resilience Ratio

Latest as of March 2025: 37.97%

Blueprint Medicines Corp asset resilience ratio. Blueprint Medicines Corp (BPMC) has an Asset Resilience Ratio of 37.97% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Blueprint Medicines Corp total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$453.99 Million

Cash + Short-term Investments

Total Assets

$1.20 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Blueprint Medicines Corp (2014–2024)

Asset resilience ratio of Blueprint Medicines Corp from 2014 to 2024. This chart shows how Blueprint Medicines Corp's Asset Resilience Ratio has changed over time. See free cash flow generation of Blueprint Medicines Corp to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Blueprint Medicines Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Blueprint Medicines Corp total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$453.99 Million	37.97%
Total Liquid Assets	$453.99 Million	37.97%

Asset Resilience Insights

Very High Liquidity: Blueprint Medicines Corp maintains exceptional liquid asset reserves at 37.97% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Blueprint Medicines Corp Industry Peers by Asset Resilience Ratio

Compare Blueprint Medicines Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Blueprint Medicines Corp Asset Resilience Ratio by Year (2014–2024)

Blueprint Medicines Corp asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Blueprint Medicines Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	43.52%	$513.47 Million	$1.18 Billion	-17.41pp
2023-12-31	60.93%	$639.36 Million	$1.05 Billion	-0.20pp
2022-12-31	61.14%	$825.28 Million	$1.35 Billion	+39.80pp
2021-12-31	21.34%	$267.17 Million	$1.25 Billion	+10.44pp
2020-12-31	10.89%	$187.21 Million	$1.72 Billion	-41.33pp
2019-12-31	52.23%	$369.62 Million	$707.69 Million	-26.63pp
2018-12-31	78.86%	$425.95 Million	$540.12 Million	+40.71pp
2017-12-31	38.15%	$273.05 Million	$715.74 Million	-19.17pp
2016-12-31	57.32%	$162.09 Million	$282.80 Million	+57.25pp
2015-12-31	0.07%	$119.00K	$178.90 Million	-0.17pp
2014-12-31	0.24%	$119.00K	$49.92 Million	--

pp = percentage points

About Blueprint Medicines Corp

NASDAQ:BPMC USA Biotechnology

Market Cap

$8.36 Billion

Market Cap Rank

#2451 Global

#911 in USA

Share Price

$129.46

Change (1 day)

+0.00%

52-Week Range

$129.46 - $129.46

All Time High

$129.46